ResearcherNingxia Medical University General HospitalNo recent work listed

Feng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7409-217X; OpenAlex author ID A5100431140. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer. Co-author DOI 10.1515/biol-2022-0538 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yongqiang Hua · 1 shared paper, 2023 · strength 0.18
- Paper PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic c… DOI 10.1515/biol-2022-0538 ↗
Fei Peng · 1 shared paper, 2023 · strength 0.18
- Paper PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic c… DOI 10.1515/biol-2022-0538 ↗
Yongfeng Hui · 1 shared paper, 2023 · strength 0.18
- Paper PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic c… DOI 10.1515/biol-2022-0538 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.